Ribonucleotide Reductase Inhibition in the Treatment of Advanced Prostate Cancer: an Experimental Approach with Hydroxyurea and Gallium Nitrate in 20 Patients

Author： Santarossa S.   Vaccher E.   Lenardon O.   Merlo A.   Errante D.   Tirelli U.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.31, Iss.10, 1995-09, pp. : 1718-1718

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiogenesis Inhibition in the Treatment of Prostate Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 10, 2009-12 ,pp. : 1070-1078

Bentham Science Publishers

Access to resources Recommend Favorite

Modeling and Proposed Molecular Mechanism of Hydroxyurea Through Docking and Molecular Dynamic Simulation to Curtail the Action of Ribonucleotide Reductase

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 4, 2016-11 ,pp. : 461-468

Bentham Science Publishers

Access to resources Recommend Favorite

What's new in the treatment of advanced prostate cancer?

By Sternberg C.N.  

European Journal of Cancer, Vol. 39, Iss. 2, 2003-01 ,pp. : 136-146

Elsevier

Access to resources Recommend Favorite

Current perspectives in the treatment of advanced prostate cancer

By Valdespino Victor   Tsagozis Panagiotis   Pisa Pavel  

Medical Oncology, Vol. 24, Iss. 3, 2007-09 ,pp. : 273-286

Humana Press, Inc

Access to resources Recommend Favorite

Baseline Quality of Life of Patients with Advanced Prostate Cancer

By Genito-Urinary Tract Cancer Cooperative Group GUT-CCG   Curran D.   Fossa S.   Aaronson N.   Kiebert G.   Keuppens E.   Hall R.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1809-1814

Elsevier

Access to resources Recommend Favorite